GSK (GSK) president acquires 9.455 notional ADS in executive savings plan

Rhea-AI Filing Summary

GSK plc reported an executive share-related transaction involving President Maya Martinez-Davis. She acquired notional American Depositary Shares within her GSK Executive Supplemental Savings Plan account. The transaction covered 9.455 ADS at a price of $50.5000 per ADS on 2026-05-07, executed on the New York Stock Exchange.

Key Figures

ADS acquired: 9.455 ADS ADS price: $50.5000 per ADS Transaction date: 2026-05-07

3 metrics

ADS acquired 9.455 ADS Notional acquisition within Executive Supplemental Savings Plan

ADS price $50.5000 per ADS Price for the 2026-05-07 plan transaction

Transaction date 2026-05-07 Date of ADS acquisition on New York Stock Exchange

Key Terms

PDMR, American Depositary Shares, GSK Executive Supplemental Savings Plan, LEI

4 terms

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS')"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

GSK Executive Supplemental Savings Plan financial

"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account"

LEI regulatory

"Details of the issuer ... LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

​

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$50.5000	9.455
		d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date of the transaction	2026-05-07
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: May 11, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What insider transaction did GSK (GSK) report in this filing?

GSK reported that executive Maya Martinez-Davis acquired notional American Depositary Shares. She obtained 9.455 ADS within her GSK Executive Supplemental Savings Plan account at $50.5000 per ADS, with the transaction executed on the New York Stock Exchange on 2026-05-07.

Who is the GSK (GSK) executive involved in the May 2026 ADS transaction?

The executive is Maya Martinez-Davis, identified as President at GSK. She made a notional acquisition of 9.455 American Depositary Shares through her GSK Executive Supplemental Savings Plan account at $50.5000 per ADS on 2026-05-07 on the New York Stock Exchange.

How many GSK (GSK) ADS did the executive acquire and at what price?

Maya Martinez-Davis acquired 9.455 notional American Depositary Shares of GSK. The plan-related transaction was priced at $50.5000 per ADS and was recorded as a single transaction executed on the New York Stock Exchange on 2026-05-07.

What type of instrument was involved in the GSK (GSK) executive transaction?

The transaction involved GSK American Depositary Shares, referred to as ADS, with ISIN US37733W2044. These were acquired on a notional basis within the GSK Executive Supplemental Savings Plan account of Maya Martinez-Davis, at a price of $50.5000 per ADS on 2026-05-07.

On which exchange was the GSK (GSK) ADS transaction carried out?

The reported transaction was conducted on the New York Stock Exchange, identified as XNYS. It involved the acquisition of 9.455 notional American Depositary Shares of GSK at $50.5000 per ADS by executive Maya Martinez-Davis on the transaction date 2026-05-07.

Is the GSK (GSK) executive ADS transaction described as a single trade?

Yes, the filing describes the transaction as a single trade. The aggregated information section notes that aggregation is not applicable, stating it is a single transaction covering 9.455 notional American Depositary Shares at a price of $50.5000 per ADS on 2026-05-07.